◄ back to all posts
Financial data and stock pages provided by
Fintel.io
◄ back to all posts
PFE: Pfizer, Inc. Stock
Written by | Jul 6, 2018
Print FriendlySIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 203,159.40 |
| Enterprise Value ($M) | 253,464.48 |
| Book Value ($M) | 65,259.00 |
| Book Value / Share | 11.74 |
| Price / Book | 3.11 |
| NCAV ($M) | -65,748.00 |
| NCAV / Share | -11.83 |
| Price / NCAV | -3.08 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.16 |
| Return on Assets (ROA) | 0.10 |
| Return on Equity (ROE) | 0.26 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.13 |
| Current Ratio | 1.40 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 47,739.00 |
| Assets | 178,983.00 |
| Liabilities | 113,487.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | n/a |
| Net Income | 16,302.00 |
| Earnings Per Share Diluted | 2.87 |
| Earnings Per Share Basic | 2.92 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 12,588.00 |
| Cash from Investing | -3,945.00 |
| Cash from Financing | -3,945.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | State Street Corp | 5.28 | -1.21 | |
| 13G/A | Vanguard Group Inc | 8.13 | -0.36 | |
| 13G/A | BlackRock Inc. | 7.70 | -7.91 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| Quarterly Report – 10-Q | ||
| Quarterly Report – 10-Q | ||
| Quarterly Report – 10-Q | ||
| Annual Report – 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 3,036,205 | 26,271,100 | 11.56 | |
| 3,151,513 | 33,847,800 | 9.31 | |
| 3,239,599 | 35,400,000 | 9.15 | |
| 3,682,462 | 33,397,900 | 11.03 | |
(click for more detail) |
|||
(click for list of largest short owners) |
|||
| Similar Companies | |
|---|---|
| NVS – Novartis AG | PANA – Panacea Acquisition Corp. |
| PBH – Prestige Brands Holdings, Inc. | PRGO – Perrigo Company plc |
| QGEN – QIAGEN N.V. |
Financial data and stock pages provided by
Fintel.io
2018/07/06
